Evidence map›Paper›PMID 31119008›Full record

ArticleThe Journal of clinical and aesthetic dermatology2019

Development of Periungual Pyogenic Granuloma with Associated Paronychia Following Isotretinoin Therapy: A Case Report and a Review of the Literature.

Conrad Benedetto, Dave Crasto, Leila Ettefagh, Navid Nami

Open access · greenAbstract readCase Reports
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Penile Granulomas Induced by Isotretinoin.Dermatology practical & conceptual · 2024
    Article
  3. [The most common benign cutaneous neoplasms of vascular, muscular, and adipose tissue and their treatment].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2022
    Review
  4. Article
  5. Childhood Vascular Tumors.Frontiers in pediatrics · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Conrad BenedettoDrs. Benedetto, Ettefagh, and Nami are with the Western University of Health Sciences in Pomona, California.
Dave CrastoDrs. Benedetto, Ettefagh, and Nami are with the Western University of Health Sciences in Pomona, California.
Leila EttefaghDrs. Benedetto, Ettefagh, and Nami are with the Western University of Health Sciences in Pomona, California.
Navid NamiDrs. Benedetto, Ettefagh, and Nami are with the Western University of Health Sciences in Pomona, California.
William Carey University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of periungual pyogenic granulomas while taking the oral acne drug isotretinoin is a known yet uncommon and potentially severe side effect of the oral vitamin A derivative. Previous reports have detailed the development of pyogenic granulomas most commonly arising at sites of previous acne lesions as well as both subungual and periungual locations, with associated paronychia, bleeding, and discomfort. This is thought to arise as a result of the nail bed's fragility and propensity toward spicule formation brought on by the proliferative action of isotretinoin. Here, we report a case of periungual pyogenic granuloma with associated paronychia in a patient taking oral isotretinoin. A review of the pathogenesis and available treatment modalities based on the current literature is provided.

Indexed as

drug-inducedIsotretinoinparonychiaperiungualpyogenic granuloma

Identifiers

PMID31119008
PMCPMC6508482
OpenAlexW2982111439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.